SCHEMBL26382001

SCHEMBL26382001

Cc1ncnc2c1ncn2[C@H]1C[C@@H](C)[C@H](O)[C@@H]1O

nearest known ligand 0.74

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
AHCY P23526 14/20 0.74
ADORA2B P29275 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26381995 0.87 AHCY (0.71) AHCYADORA2B
SCHEMBL26382107 0.85 AHCY (1.00) AHCYADORA2B
SCHEMBL17302275 0.85 AHCY (1.00) AHCYADORA2B
SCHEMBL26381999 0.83 AHCY (0.73) AHCYADORA2B
SCHEMBL1908637 0.80 AHCY (0.55) AHCY
SCHEMBL26382003 0.79 AHCY (0.71) AHCY
SCHEMBL26230808 0.78 AHCY (0.46) AHCYADORA2B
SCHEMBL13693169 0.77 AHCY (0.50) AHCYADORA2B
SCHEMBL29885678 0.76 AHCY (0.63) AHCY
SCHEMBL13211913 0.76 AHCY (0.53) AHCY

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230302003-A1 COMPOSITIONS AND METHODS FOR TREATING A CORONAVIRUS INFECTION ANTIRNA INCORPORATED 2023-09-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230302003-A1 COMPOSITIONS AND METHODS FOR TREATING A CORONAVIRUS INFECTION AHCY, AHCYL1, BHMT AHCY 1/4885ADORA2B 1263/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.